These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21198850)

  • 1. Late catch-up phenomenon associated with stent fracture after sirolimus-eluting stent implantation: incidence and outcome.
    Serikawa T; Kawasaki T; Koga H; Orita Y; Ikeda S; Goto Y; Shintani Y; Kajiwara M; Tanaka H; Fukuyama T; Koga N
    J Interv Cardiol; 2011 Apr; 24(2):165-71. PubMed ID: 21198850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes.
    Umeda H; Kawai T; Misumida N; Ota T; Hayashi K; Iwase M; Izawa H; Sugino S; Shimizu T; Takeichi Y; Ishiki R; Inagaki H; Ozaki Y; Murohara T
    Circ Cardiovasc Interv; 2011 Aug; 4(4):349-54. PubMed ID: 21813403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents.
    Kim JS; Lee SY; Lee JM; Yoon YW; Ahn CM; Kim MH; Min PK; Ko YG; Hong BK; Choi D; Kwon HM; Jang Y; Shim WH
    Coron Artery Dis; 2009 Jan; 20(1):59-63. PubMed ID: 19008765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical impact of fracture of drug-eluting stents widely used in current clinical practice: comparison with initial platform of sirolimus-eluting stent.
    Park MW; Chang K; Her SH; Lee JM; Choi YS; Kim DB; Kim PJ; Cho JS; Choi MS; Baek JY; Park CS; Yoon SG; Chung WS; Seung KB
    J Cardiol; 2012 Sep; 60(3):215-21. PubMed ID: 22890068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation.
    Lee SH; Park JS; Shin DG; Kim YJ; Hong GR; Kim W; Shim BS
    Am J Cardiol; 2007 Aug; 100(4):627-30. PubMed ID: 17697818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation.
    Umeda H; Gochi T; Iwase M; Izawa H; Shimizu T; Ishiki R; Inagaki H; Toyama J; Yokota M; Murohara T
    Int J Cardiol; 2009 Apr; 133(3):321-6. PubMed ID: 18342960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation.
    Kuramitsu S; Iwabuchi M; Haraguchi T; Domei T; Nagae A; Hyodo M; Yamaji K; Soga Y; Arita T; Shirai S; Kondo K; Ando K; Sakai K; Goya M; Takabatake Y; Sonoda S; Yokoi H; Toyota F; Nosaka H; Nobuyoshi M
    Circ Cardiovasc Interv; 2012 Oct; 5(5):663-71. PubMed ID: 23011266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical and angiographic outcomes of patients with sirolimus-eluting stent fracture.
    Kim U; Kim DI; Kim DK; Seol SH; Jang JS; Yang TH; Kim DK; Kim DS; Min HK; Choi KJ
    Int J Cardiol; 2012 Jun; 158(1):83-7. PubMed ID: 21482439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
    Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
    J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents.
    Almalla M; Schröder JW; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2013 Mar; 24(2):165-70. PubMed ID: 23242011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis.
    Lee CW; Park CB; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):104-8. PubMed ID: 17139669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation.
    Song HG; Park DW; Kim YH; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Han S; Seong IW; Lee NH; Lee BK; Lee K; Lee SW; Nah DY; Park SJ
    J Am Coll Cardiol; 2012 Mar; 59(12):1093-100. PubMed ID: 22421303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological features of in-stent restenosis after sirolimus-eluting stent versus bare metal stent placement.
    Abe S; Yoneda S; Kanaya T; Oda K; Nishino S; Kageyama M; Taguchi I; Masawa N; Inoue T
    Cardiovasc Pathol; 2012; 21(2):e19-22. PubMed ID: 21489821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
    Kimura T; Morimoto T; Nakagawa Y; Kawai K; Miyazaki S; Muramatsu T; Shiode N; Namura M; Sone T; Oshima S; Nishikawa H; Hiasa Y; Hayashi Y; Nobuyoshi M; Mitudo K;
    Circulation; 2012 Jan; 125(4):584-91. PubMed ID: 22203694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.
    Almalla M; Schröder JW; Pross V; Stegemann E; Marx N; Hoffmann R
    Am J Cardiol; 2011 Aug; 108(4):518-22. PubMed ID: 21624553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.